This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration. Need a new registration confirmation email? Click here
NuPathe(PATH) is a specialty pharmaceutical company focused on the development and commercialization of therapeutics for diseases of the central nervous system, including neurological and psychiatric disorders. This stock is trading up 17.9% at $3 in recent trading.
Today's Range: $2.64-$2.99
52-Week Range: $1.90-$8.95
Three-Month Average Volume: 34,700
>>6 Drug Stocks Unworthy of Biotech Bull Market
From a technical perspective, PATH has started to trigger a big breakout trade today now that the stock has taken out some near-term overhead resistance at $2.48 with decent volume. As soon as that breakout was triggered, PATH ripped higher to its current price of just under $3.
Traders should now watch PATH to trigger its next big breakout trade on a high-volume move and close over $3 to $3.19. If we get that action soon, then look for PATH to re-test its 200-day moving average of $4.31. Look for volume that's well above 34,700 on a close over $3 to $3.19.